Showing posts with label Bioscrip Settles with DOJ. Show all posts
Showing posts with label Bioscrip Settles with DOJ. Show all posts

Thursday, January 16, 2014

Bioscrip Settles with DOJ, Novartis Accused of Paying Kickbacks to Pharmacies for Exjade Patient Adherence Program

Novartis Pharmaceuticals has been accused by the U.S. government and 26 states of a kickback scheme related to its iron-reduction drug Exjade.
On January 8, 2014, U.S. District Judge Colleen McMahon in Manhattan unsealed a complaint alleging the Swiss drug maker kicked referrals and rebates to a specialty pharmacy, BioScrip Inc., to encourage patients to refill prescriptions. The complaint accuses Novartis of inducing BioScrip "to set aside its independent clinical judgment and promote Exjade refills for Novartis" by emphasizing the drug's benefits, and concealing its potentially life-threatening side effects.
Novartis maintains that its interactions with BioScrip were part of its efforts to assure patients were properly managing serious health conditions through the use of Exjade
- See more at: http://www.policymed.com/2014/01/bioscrip-settles-with-doj-novartis-accused-of-paying-kickbacks-to-pharmacies-that-increased-exjade-prescriptions.html#sthash.fkYwvlT4.dpuf